Aurora is trying to leave the worst cannabis-stock habits behind: Q3 FY2026 medical cannabis revenue set a record, management is exiting weaker Canadian consumer lanes, and the balance sheet has cash. The catch is that IFRS losses, Bevo restructuring, internal-control weaknesses, and an open ATM keep the turnaround on probation.
References
Sources used in this report
SEC submissionsSEC submissions JSON for CIK 00016835412026-05-13 · Issuer identity, ticker, exchange, SIC, fiscal year end, and filing inventory.SEC XBRL companyfactsSEC companyfacts for CIK 00016835412026-05-13 · Primary IFRS companyfacts for annual revenue, profit, assets, liabilities, equity, and cash flow.Annual reportFY2025 Form 40-F2025-06-18 · Annual filing wrapper and audited annual reporting package.Annual MD&AFY2025 MD&A2025-06-18 · Business overview, segment revenue, margins, cash flow, balance sheet, strategy, risk factors, and ICFR weaknesses.Annual information formFY2025 Annual Information Form2025-06-18 · Corporate structure, subsidiaries, governance, directors and officers, risk factors, and audit committee information.Interim filingQ3 FY2026 Form 6-K2026-02-04 · Quarterly reporting package for the period ended December 31, 2025.Interim financial statementsQ3 FY2026 financial statements2026-02-04 · IFRS income statement, balance sheet, cash flow, segment, and geographic revenue detail.Interim MD&AQ3 FY2026 MD&A2026-02-04 · Management discussion of Q3 results, segment mix, outlook, free cash flow, and restructuring context.Company earnings releaseQ3 FY2026 earnings release2026-02-04 · Q3 revenue, medical cannabis record, adjusted EBITDA, free cash flow, FY2026 outlook, consumer exit, and Bevo transaction summary.Prospectus supplementFebruary 2026 ATM prospectus supplement2026-02-13 · US$100 million at-the-market share issuance capacity and intended use of proceeds.Government regulatorHealth Canada licensed cultivators, processors and sellers2026-05-13 · Canadian cannabis licensing framework and medical-purpose seller context.Government regulatorHealth Canada cannabis for medical purposes information2026-05-13 · Medical-cannabis access context and regulator caution that legal cannabis products are not approved therapeutic products unless separately authorized.